A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells
about
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Prostate cancer relevant antigens and enzymes for targeted drug deliveryPTEN knockout prostate cancer as a model for experimental immunotherapyEmerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cellsHighly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody.Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics.Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.A new class of bispecific antibodies to redirect T cells for cancer immunotherapy.Targeting the prostate-specific membrane antigen for prostate cancer therapy.Development and prospects for bispecific antibody-based therapeutics in cancer and other applications.Clinical pharmacology of bispecific antibody constructs.Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells.Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats.Recent advances of bispecific antibodies in solid tumors.Tumor-associated antigens for specific immunotherapy of prostate cancerT cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeuticsADME for Therapeutic Biologics: Antibody-Derived Proteins and Proteins with Novel Scaffolds
P2860
Q24644083-9A0EC13D-5098-4521-9696-B0BB8DC7DD1AQ27013843-9B16D19B-7D8B-4F9B-BF32-6951DCA60A79Q33728431-94E7B4AC-2E99-4531-9441-4AAF785503BEQ33833475-66375C41-15AC-4F33-9853-4230DA3FBDA1Q33966998-67EE5CDC-1D14-465C-8400-8116D0E0DC01Q34503084-26AC53F1-6ED8-4CA8-B38C-B28D72593E3AQ35980893-10171287-E3E7-42A9-A70A-C827AB567ABBQ37218120-BA5EC058-65D7-4BA0-8292-90E2309B3004Q37304489-049C4595-D557-4F99-93C3-0813BF3113A9Q37521861-03E4C5FC-1F23-4523-BD73-791E5CC0DF77Q37698921-450E0C4B-7068-4884-91BF-F24C5EBED26FQ37773273-A190DB36-8E98-46E7-AE73-B9CA97659E03Q38090680-B2CAE64E-3007-4B5F-9F80-9B7EA9DB31B8Q38364459-C20F3397-5C13-4F60-AE10-A70EAA17ECABQ39222901-4D84F9A9-E5ED-4E73-9176-B95BF8EAB485Q39323781-B2E761C5-2286-4D0C-908C-1628CDBD63AFQ39548378-56823C76-C39C-4AA2-A5D7-7BF688EBD039Q41696278-60155C2D-FAB9-404C-A3A6-D6EDF7756F2AQ41977894-12DEAE59-07AE-4D73-BE41-0FC2E24646EDQ47570404-323730C8-F819-43E4-8129-C92F266ED600Q50528363-DF241CCC-0CC8-4DEB-8D23-4178177E57A6Q54377694-D839B156-DA32-45AB-9E5F-56929E9FE490Q57151874-03D5804B-B815-4D87-A532-57860E36B3FBQ58869554-D1194B9D-634B-4485-A3A1-CE1B7B0A7B44
P2860
A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A bispecific diabody directed ...... lysis of prostate cancer cells
@en
A bispecific diabody directed ...... lysis of prostate cancer cells
@nl
type
label
A bispecific diabody directed ...... lysis of prostate cancer cells
@en
A bispecific diabody directed ...... lysis of prostate cancer cells
@nl
prefLabel
A bispecific diabody directed ...... lysis of prostate cancer cells
@en
A bispecific diabody directed ...... lysis of prostate cancer cells
@nl
P2093
P2860
P1476
A bispecific diabody directed ...... lysis of prostate cancer cells
@en
P2093
A Katzenwadel
D Gierschner
U Elsässer-Beile
U Wetterauer
W Schultze-Seemann
W W A Schamel
P2860
P2888
P356
10.1007/S00262-007-0348-6
P577
2007-06-20T00:00:00Z
P5875
P6179
1039365304